Internal Medicine Department, Dermatology, Universidade Estadual de Londrina, Londrina, PR, Brazil.
Clinical Surgery Department, Ophthalmology, Universidade Estadual de Londrina, Londrina, PR, Brazil.
PLoS Negl Trop Dis. 2020 Sep 21;14(9):e0008585. doi: 10.1371/journal.pntd.0008585. eCollection 2020 Sep.
Hansen's disease (HD) belongs to the group of neglected diseases and can cause physical deformities and disabilities, in addition to leading to social discrimination. Ocular involvement in HD is estimated at 70-75% worldwide. About 10-50% suffer from severe ocular symptoms and loss of vision occurs in approximately 5% of cases. Ocular changes may persist or worsen even after patients are considered cured and it is necessary to better understand these conditions in order to determine the need for additional public policies. The objective of this study was to identify the prevalence of ocular involvement in patients with HD at two specialist referral centers for treatment of the disease. A cross-sectional study was conducted with ophthalmological evaluations of patients with HD from June 2017 to June 2018. Diagnostic ocular findings, corrected visual acuity, and refractive error were described. Findings were correlated with patients' clinical and epidemiological variables. A total of 86 patients were evaluated, with a mean age of 50.1 years, predominantly males (59.3%), and with multibacillary HD (92%). The prevalence of ophthalmologic changes was 100% and the most common were dysfunction of the Meibomian glands (89.5%) and dry eye syndrome (81.4%). Cataracts were observed in 22 patients (25.6%), but best corrected visual acuity was normal or near normal in 84 patients (97.7%) and there were no cases of bilateral blindness. Patients with some degree of physical disability had more ophthalmological alterations, involving both the ocular adnexa (p = 0.03) and the ocular globe (p = 0.04). Ocular involvement is common in patients with Hansen's disease, reinforcing the importance of ophthalmologic examination in the evaluation and follow-up of these patients.
汉森病(HD)属于被忽视疾病的范畴,除了导致社会歧视外,还会导致身体残疾。据估计,全世界有 70-75%的 HD 患者会出现眼部受累。约 10-50%的患者会出现严重的眼部症状,约 5%的患者会出现视力丧失。即使患者被认为已治愈,眼部变化仍可能持续或恶化,因此需要更好地了解这些情况,以便确定是否需要额外的公共政策。本研究的目的是确定两家治疗 HD 的专科转诊中心的 HD 患者的眼部受累患病率。这是一项横断面研究,对 2017 年 6 月至 2018 年 6 月期间的 HD 患者进行了眼科评估。描述了诊断性眼部发现、矫正视力和屈光不正。将发现与患者的临床和流行病学变量相关联。共评估了 86 例患者,平均年龄为 50.1 岁,主要为男性(59.3%),且均为多菌型 HD(92%)。眼部病变的患病率为 100%,最常见的是睑板腺功能障碍(89.5%)和干眼症(81.4%)。22 例患者(25.6%)观察到白内障,但 84 例(97.7%)的最佳矫正视力正常或接近正常,且无双侧失明病例。存在某种程度的身体残疾的患者眼部改变更多,涉及眼附属器(p=0.03)和眼球(p=0.04)。HD 患者眼部受累很常见,这强调了眼科检查在这些患者的评估和随访中的重要性。